to I by everyone. despite Perrigo afternoon delivering the pandemic, each delivering Consumer Self-Care Thank again you, continued as of want for and consumers all patients good year I by their for during needed and today's product and in begin COVID-XX call efforts colleagues transformation, Brad, products for commitments, once on major driving again our our financial discontinuation. our thanking a have once
the revenue Before Ireland. we legitimate process outcome to violate I earnings, dive into of review of Assessment issuance by Amended Irish today's that High Notice a want the The moment in discuss the judicial take the Irish ruled expectations. company's to Court not from did
exclude obviously to to judge's Irish are disappointed going with property legal the Perrigo's revenue right after trade revenue re-characterized XXXX. had of to that intellectual retrospectively decision and We issue warning without the the back assessment disposals
While appeals will tax everyone today's is in this the due was to payment if I our of process did not Likewise, upside that decision to appeals assessment no the decision due no only merits not judge judge to our or on only the today has the considering process that was actual I we tax we now based Perrigo news merits eventually -- review. final We commission, the million under be decision directly wasn't and there US Self-Care be rule favor, law. progress to want merits take revenue ultimately would you income the tax commission, Irish-US double make substantially now, argument resolved to be transformation, believe the was judicial Irish exposures strongly was competent bearing the the Ireland. and did while the tax determination to success determined a whether the and matter a Athena remind of appeal target authorities our optimistic on The will the $XXX proceed merits, it review treaty. and the tax are review also agreement the Perrigo Perrigo not likely remind we were judicial the tax is of argument and matters prevail. tax to the history confident value need of the wrong US on all is Perrigo under case overall Irish We on resolving Irish case, an the tax this case on on assess of of accepted by pursue could remain the to and that of quarter. uncertainty achieving program through any and to by and losses. be But that of the have decision appeal this years. ultimately, with avoid unsuccessful US on our mutual or bad Consumer taxation, assessment to that the which Notably, reduce
this of company So how back progressing are focus to the our the how I'd performing and call like against transformation and business plans. rest is get we on the to
XX the on meaningful recap notably portfolio, made Slide our partially funded are made consumer have e-commerce, added most six strategy, completed that we We've a two with intense start divesting Self-Care in over we've businesses. Care. Let's recapture expanding new for advantage. that the on transformation. go-to-market purchases platform the acquisitions to past growth by our a bolt-on These us months progress significant Oral investments our Perrigo in With non-core most enabling notably also X of focus on were
created week also million insights to product to growth. to sophisticated more teams Our at with clock organic a commercial and provide around our American corporate drive ability greater talent, announced and and to enhance headquarters and the of fuel stars. development customers the more launched foster throughout internal last of analytics the new products business located teams both consumers and essential Rapids. internal through are in North up coming pipeline be world-class leadership innovation pandemic, have $XXX and to have And infused We've organization. and company least our from platform with global external new downtown of the R&D mile positions working our intelligent have the in our designed experience been than our half always further medical collaboration we within To talent a to attract consumer promotions Grand
cash not what while accomplished for And the entire in time. quarters. I'm believe the a short reflect is invested the between eight generating will ago, dividend faced significantly just The for support infrastructure exceeding increased ultimately the growth by believe of we Board million proud service, does such our savings meeting or and Perrigo spending the calendar more the team project time in have reductions two did yet now the predictably XX% this end balance $XXX same that the team Board while of the compared Directors years I operating than of sheet. expense we million year. and and achievements, purchase $XXX valuation has all it increased these financial and accumulating authorized offset on this $XXX momentum to the far stock of already Perrigo year. through to at initiative we've while commitments to so in company's and headwinds billion which Our nearly reason, $X they've In all total, million M&A, consecutive more than the
achieved adjusted from than the is grow annual we coupled it and as The sizable [ph] operating cost enhancement, as result The at efficiencies. surpassed peers, On to add grow growth, We growth next capability of Though by leverage X% highlighted. long-term margin growth a those our of illustrated sales peers CAGR sales confident average, savings on X% target in our revenue targets and peer is expected initiatives targets and basis discount a a with X. the operating rate to of expectations. through operating organic X% three years. we growth growth we compound be Turning gross Slide our estimate faster X% net consumer growth CPG expenses expect remain combination leading revenue investments. by income analysts traded here. X.X% to manufacturing technology to income to which X% These mix, margin and come have another over
remain targets consumer Our growth unchanged.
discuss the and the as Now on next year-to-date our performance next slide. let's for quarter shown
XX% was behind versus the both start year we early to It up results Perrigo's of ago Rx operating of X.X% our plus but versus our the and X% that I'll X.X% and guidance $XX as a consumer organic our more up times, is through Adjusted just team remarkably transformation. quarter X.X% EPS Worldwide a growth for especially a with a our of plus and recoveries attribute net Consumer the successful business we the versus plus the more XX% XX,XXX sales This were prior net recall. be growth revenue this affected We prior reserve with the and albuterol year-to-date, very ago, plus recall. down XX% revenues revenue one diversified we year of members of by Worldwide worth consolidated up were compares Consumer are conjunction about growth a CSCI, to detail of better X% consumer importance related Consumer the CSCA, growing execution in noting achieved X% goal year organically. than quarter share Note, the ago, of walk International, to versus for model, billion, after basis, XXXX. recall to Self-Care plus This consolidated albuterol quarter, $X.X the revenue net is transformational at strength more transformation. Americas, X%. incremental recall-related in to than few Consumer well Consumer XX%, the the billion. year, Worldwide our sales businesses. negatively X% grew to $X.X EPS in year-to-date business, achieving net that durable expected costs, a line divestiture prior is our in our underlying during despite up On year third sales X.X% and Worldwide is in our sales early activities, net profit Slide growth despite is sales than and than goals X% products established our are and the costs, dedication Adjusted above and including several We growth today Self-Care goal. a in which XX $X.XX in albuterol grew this per COVID-related you Rosemont. strong agility Year-to-date, sales the consumers the X, believe which these points difficult On quarter, in in was Worldwide organically million the growth Consumer reaffirmed the see is albuterol moments. year-to-date worldwide. of Third which business flat discontinuance. year validates years just ongoing less essentially basis organically, Self-Care focus base guidance $X.XX strong
the As once Americas pandemic Slide robust this was XX, the has primary growth quarter, Self-Care Consumer engine. in again performance third shown company's on remained through and
Third were health, and product categories. net digestive led X%. benefiting quarter net a by consumers regimented these year X% ago, increased sales growth to Oral sales e-commerce OTC up switching highly with allergy, organic care, from versus pain the leaders in
designed demand are prevent quarter, and CSCA, the levels testament for spread that organic Pain our the acquisition the March-April cough/cold from benefited the mask a illnesses a and from late heard products consumer well benefited brand in we store pantries to market the perspective you've Nutrition continued cold/cough from grew to to and COVID-related revenues measures discussed major product For also equivalent products the earlier. due branded still growth. I re-launch our which customer, distancing launch. the e-commerce demand, as benefited that from to to care more quarter, lower Digestive from Similar new above COVID, investments to XXX% social Prevacid. year-over-year the than consumer attribute from were year-over-year are others, continued Dr. believe as of what a in of and year of benefited oral the belief down we last launch health year-ago surge. Voltaren Fresh
CSCA, strong overall of that think, guidance. our in into are balance This year. the very also quarter other There weaker benefiting built assume for CSCA within the projections assumption is for in strong year are two mentioning. US our the was it notable Importantly, cough/cold very an worth are season. a trends I another all, All
store that behavior tried to pandemic. on of Slide XX% buying shopping data from consumer study, XX% released to they important a intend noted that shown they which that's consumers first is to brand began. there McKinsey brand big. the for COVID this new with those behavior first very store is XX% continue recently shift It since have time, consumer tried The store shows According a shopping have the brand, a to survey XX, reporting of occurring is of survey. the through in
survey behaviors as big behavior shown We've shift which huge omnichannel data that other seen The to highlighted digital shopping in and was in our in ourselves XX. Slide the e-commerce. a in
a measuring done past. take to to we've and consumer mean what data. IRIs our from data or of This minute me out Let measured omnichannel the multi-outlet I refers sell way in reported a Historically, broader than by CSCA takeaway data. explain MULO
importantly, underestimates sell-out club through it channel. MULO insightful, capture more does the While not significantly, store and e-commerce
in such more which e-commerce is refer mortar data. market a buying to brick has to much as reflect from consumer habits our behavior. was overall component and it by our as As this become consumer to larger accurately and to of data online, critical turbocharged e-commerce continue omnichannel include COVID, to share shift sales, We
were first omnichannel now X.X%, and OTC point Perrigo store data the MULO IRI data category e-commerce analyze, within by store Perrigo measure, with and Perrigo for data data is share of on store and total results the this this customers. down brand omnichannel category. up brand Perrigo's slide sale factory But quarter, OTC driver OTC difference Perrigo down For which result the measure quarter, total we to IRI the which provided lesser brand from Perrigo we third is revenues quite is actually performance omnichannel the clearly overall few brand The whole the up very total X.X%. set, is for in the Perrigo total quarter, broader and third is clearly share omnichannel share top investments of and of OTC of business. of and shipments X.X% declined category, now was MULO a store which can now total total time, and can the In X.X%, in OTC point high also has store that omnichannel the this panel extent X.X%. OTC includes faring of sale its the and of and e-commerce compare the with this which channel MULO a over for major X.X% grew data compiled brand but at wholesale this X.X% The shows sales. CSCA past demonstrates sales, data, is down plus benchmark What data category, years aligned between better market area in a the notably, plus still total in to MULO fully the dramatic. club entire
on looking across Certain is were while from CSCI versus impact negatively Turning usage, down increased International. mixed Net Self-Care lockdowns to the impacted at a X% year of bit others benefited by sales Consumer from ago. bag when a behavior. Europe. consumer were our a COVID-related business categories
or by were than and of as across growth of US, same the category, driven supplement the school in grew finally treatments sales Davitamon XLS category products brand to selling BMS within the strong by the management side, to weight e-commerce Solpadeine, new These new lower most as pain for more driven closings. well the the the innovations by businesses. positive due products the life the as in cough/cold On brand fever reason reduce offset
performed peers the is near Slide total both business levels, Europe. better in to third we XX on why other see this a total little for business in you and as has in pre-COVID than which Importantly, CSCI outperformed the quarter. recovering Self-Care branded explains Perrigo Consumption anticipated market
the France, Ireland. countries and less Italy, including Spain, put were UK lockdowns into recent are restrictive Belgium, in that closely albeit Germany, effect we monitoring somewhat However,
on be these We plans from will in need lockdowns. the changes fourth quarter adjust our as based behavior consumer resulting
were offset $XX for Turning as albuterol early reserve prior of million Rx Net September or recovered sales quarter, base than million below levels. $XX the albuterol during year the which recall in the refer first products business expected in net of Rx. to in what and million more discontinued the still completely $XX the the pre-COVID to sales quarter albuterol established million were faster The business margin than quarter products. third albeit a $X the I'll than Rx and half lower were lower discontinuance by as it's during underlying excludes
as can were lockdowns to you above reported year reported closed is ago As IQVIA see, news. QX, Rx quarter, were X.X% which base down declines. ago offices similar which QX's profitable to and levels sales big derm return when prescriptions Notably, derm and doctors' versus is in good a year business decline topicals in topicals our pre-COVID from by XX% the most due improvement
halting our full re-launch Rx when stabilizing business, base business. the is the clearly albuterol on patient thing is will solved, new growth this we the of a while a and problem and pipeline our important generating sales to So for products we safety, in restart is did have we hit cash right to meantime, business
So year by sales worldwide targets, to operating organic to restart on in net XX% is meeting year-to-date, X% growth summarize, revenue than X% consolidated or full adjusted our highlighted X% are place and revenue earlier plans business expected plus and And a organic consumer growth. than up were growth our income exceeding Rx. greater plus
products the focused we continuing double-digit looking the demand QX, e-commerce chain consumer up and supply activities. to CSCI new demand strength reaffirmed the off there on products albuterol year; accretion two, now strong, in the Within in cough/cold between impact one, between assume of built four, remains repurchases the fully three, by from ending by our So Perrigo's following: continued the adjusted transformation and a now QX guidance are decline market; in our in businesses and the the our EPS driven range, and of with our the even end CSCA for rest Rx is the certain with in sustained; keeping remain the XXXX, essential no replenished, and QX of in we surge share getting base recoveries US year five, end in; categories and new consumer no year. for major
So heck growing been line, of a again. Perrigo it's year. bottom a is
we is we more is continue Perrigo remain Irish Our to where believe the normal world to transformation Ray to and self-care, will e-commerce again, the by details. that, will Consumer that working grow well are And and value to Self-Care confident I capitalizing a Ray? new before. with positioned discuss the ever we ultimately Noah. call turn on prevail And than financial tax important
